Bristol-Myers' stock price increased to $28 in electronic trading after the company announced a successful clinical trial for its cancer drug.
Bristol shares rose $ 1.30 , or 5 percent , to $ 28.20 , after closing at $ 26.90 on the New York Stock Exchange .